Awards Bibliography

Award for Excellence, Academy of Managed Care Pharmacy, 2004
For research paper Randomized Controlled Trial of a Dose Consolidation Program. JMCP. September/October 2004.

Research Excellence Award, International Society for Pharmacoeconomics and Outcomes Research, 2004
For research paper Verification of a Decision Analytic Model Assumption Using Real-World Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s). AJMC. December 2003.

Award for Excellence Academy of Managed Care Pharmacy, 2003
For research paper Do Decision Analytic Models Identify Cost-Effective Treatments? JMCP. September 2003.

Research Bibliography

Melnick S, Motheral BR. Is “Value-Based” Value-Wasted? Examining Value-Based Insurance Designs Through the Lens of Cost-Effectiveness. Journal of Managed Care Pharmacy. 2010:16(2):134-140.

Martin B, Motheral BR, et al. “Good Research Practices for the Conduct of Observational Database Studies” In Analysis of Observational Health Care Data Using SAS, 1st edition, Faries DE ed. 2010.

Motheral BR. 2008: A Tipping Point for Disease Management? Journal of Managed Care Pharmacy. 2008:14(7):643-649.

Delate T, Mager DE, Sheth J, Motheral BR. Clinical and Financial Outcomes Associated With a Proton Pump Inhibitor Prior-Authorization Program in a Medicaid Population. American Journal of Managed Care. 2005;11(1):131-139.

Delate T, Fairman KA, Carey SM, Motheral BR. Randomized Controlled Trial of a Dose Consolidation program. Journal of Managed Care Pharmacy. 2004;10(5):396-403.

Cox ER, Henderson R, Motheral BR. Health plan member experience with point-of-service prescription step therapy. Journal of Managed Care Pharmacy. 2004;10(4):291-298.

Motheral BR, Henderson R, Cox ER. Plan-sponsor savings and member experience with point-of-service prescription step therapy. American Journal of Managed Care. 2004;10:457-464.

Motheral BR, Heinle SM. Predictors of Satisfaction of Health Plan Members with Prescription Drug Benefits. American Journal of Health-System Pharmacy. May 15, 2004;61:1007-1014.

Delate T, Simmons VA, Motheral BR. Patterns of Use of Sildenafil Among Commercially-Insured Adults in the United States: 1998-2002. International Journal of Impotence Research. June 2004;16:313-318.

Delate T, Gelenberg AJ, Simmons VA, Motheral BR. Trends in the Use of Antidepressant Medications in a Nationwide Sample of Commercially Insured Pediatric Patients, 1998-2002. Psychiatric Services. 2004;55(4):387-391.

Delate T, Henderson RR, Motheral BR. Financial Impact of Benefit Design Choice for Non-Sedating Antihistamines. January 2004. Available on the Express Scripts website.

Motheral BR, Kolling B, Parker A. Drug Trend Report, featuring The Pharmacy Benefit Guide 2003. June 2004. Available on the Express Scripts website.

Delate T, Motheral BR. Conclusions of Cost-Effectiveness for an Asthma Intervention may not be Warranted. Journal of Allergy and Clinical Immunology. 2003;111(3):654. (Letter to the Editor)

Fairman KA, Motheral BR, Henderson RR. Retrospective, Long-Term Follow-Up Study of the Effect of a Three-Tier Prescription Drug Copayment System on Pharmaceutical and Other Medical Utilization and Costs. Clinical Therapeutics. 2003;25(12):3147-3161.

Cox ER, Motheral BR, Mager D. Verification of a Decision Analytic Model Assumption Using Real-World Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s). The American Journal of Managed Care. 2003;9(12):785-794.

Cox ER, Motheral BR, Frisse M, Behm A, Mager D. Prescribing COX-2s for Patients New to Cyclo-oxygenase Inhibition Therapy. The American Journal of Managed Care. 2003;9(11):735-742.

Fairman KA, Motheral BR. Do Decision-Analytic Models Identify Cost-Effective Treatments? A Retrospective Look at Helicobacter Pylori Eradication. Journal of Managed Care Pharmacy 2003;9(5):430-440.

Cox ER, Motheral BR, Henderson RR, Mager D. Geographic Variation in the Prevalence of Stimulant Medication Use Among Children 5 to 14 Years Old: Results From a Commercially Insured US Sample. Pediatrics 2003;111(2):237-243.

Motheral BR, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D, Martin BC, Stang P. A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective Databases. Value In Health 2003;6(2):90-97.

Motheral BR, Littlejohn S, A Winning Formula. Canadian Healthcare Manager. www.chmonline.ca April 2003.

Motheral B, Sheth J. Financial Consequences of Drug Benefit Plans. Journal of the American Medical Association 2003;289(4).

Motheral BR, Teitelbaum F, Frear R. The Pharmacy Benefit Guide 2002. February 2003.

Roe CM, McNamara AM, Motheral BR. Sex Differences in Prescription Medication Use and Costs in a Large, National Commercial Sample: 1999.

Roe CM, McNamara AM, Motheral BR. Use of Chronic Medications Among a Large, Commercially-Insured U.S. Population. Pharmacoepidemiology and Drug Safety 2002;11(4):301-309.

Roe CM, McNamara AM, Motheral BR. Pharmacoepidemiology: Gender- and Age-Related Prescription Drug Use Patterns. The Annals of Pharmacotherapy 2002;36:30-39.

Motheral BR, Cox ER, Mager DE, Henderson RR. 2000 Prescription Drug Atlas, January 2002. Available on the Express Scripts website.

Motheral BR, Fairman KA. Effect of a Three-Tier Prescription Copay On Pharmaceutical and Other Medical Utilization. Medical Care 2001;39(12):1293-304.

Fairman KA, Motheral BR, Teitelbaum F. Effects of Employee Salary and Chronic Disease on Response to a Drug Copayment Increase. August 2001. Available on the Express Scripts website.

Henderson RR, Motheral BR. Mail Order Pharmacy: A Case Study. Drug Benefit Trends 2001;13(9):28-38.

Motheral BR, Schafermeyer K. Managed Health Care In: R. McCarthy and K. Schafermeyer (eds.) Introduction to Health Care Delivery: A Primer for Pharmacists, 2001.

Cox ER, Motheral BR and Fairman K. Exhaustion of Prescription Benefits And Medicare Beneficiaries’ Disenrollment from Managed Care. Journal of the American Medical Association;284:2596-2597.

Grizzle AJ, Olson BR, Motheral BR, Armstrong EP, Abarca J, Cox ER. Therapeutic Value: Who Decides? Pharmaceutical Executive 2000;20(11):84,86,88,90.

Fairman KA, Motheral BR. Evaluating Medication Adherence: Which Measure Is Right For Your Program? Journal of Managed Care Pharmacy 2000; 6(6):499-506.

Motheral BR, Delate T, Shaw J, Henderson R. The Effect of a Closed Formulary in the Face of Real-Life Enrollment and Disenrollment Patterns. Journal of Managed Care Pharmacy 2000;6:293-297.

Fairman KA, Motheral BR. Helicobacter Pylori eradication in Clinical Practice: Retreatment Rates and Costs of Competing Regimens. Annals of Pharmacotherapy 2000;34:721-728.

Teitelbaum F, Martinez R, Parker A, Henderson R, Roe C, Kolling B. Drug Trend Report 1999. June 2000.

Motheral BR, Grizzle AJ, Armstrong EP, Cox E, Fairman K. Role of Pharmacoeconomics in Drug Benefit Decision-Making: Results of a Survey. Formulary 2000;35:412-421.

Motheral BR, Cox ER, Daniels CE. Pharmacoeconomics and Outcomes Research, Evaluating the Studies. Journal of Managed Care Pharmacy January/February 2000;6 (suppl).

Roe CM, Motheral BR, Teitelbaum F, Rich MW. Compliance With and Dosing of Angiotensin-Converting-Enzyme Inhibitors Before and After Hospitalization. American Journal of Health-System Pharmacy 2000;57:139-145.

Motheral BR, Henderson RR. The effect of closed formularies on prescription drug use and costs. Inquiry 1999-00 Winter;36(4):481-91.

Motheral BR, Henderson R. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. The American Journal of Managed Care 1999;5:1383-1394.

Roe CM, Motheral BR, Teitelbaum F, Rich MW. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure. American Heart Journal 1999;138:818-825.

Motheral BR. Research methodology: Hypotheses, measurement, reliability, and validity. Journal of Managed Care Pharmacy. 1998;4(4):382-390.

Motheral BR. Fairman KA. Patient education programs and continuance with estrogen replacement therapy: Evaluation of the Women’s Health Exchange. Menopause 1998;5(1):35-41.

Motheral B, Teitelbaum F, Toan B. The ‘Shoe-Box Effect’. Health Affairs. 1998;17(3):284.

Motheral BR, Schafermeyer KW. Managed Care. In: The U.S. Healthcare System: A Primer for Pharmacists, Aspen Publishers, 1998.

North American Menopause Society Consensus Panel. Achieving Long-Term Continuance of Menopausal ERT/HRT: Consensus Opinion of the North American Menopause Society. Menopause 1998;5:69-76.

Motheral BR. Outcomes Management. Hospital Pharmacy 1998;33:240-243. Lingle EW, Motheral BR, Watrous ML. estimating the Financial Impact of Employer Mandates on Independent Retail Pharmacies. Journal of Research in Pharmaceutical Economics.1997;8:43-54.

Motheral BR. Outcomes Management: The Why, What, and How of Data Collection. Journal of Managed Care Pharmacy. 1997;3(3):345-351.

Motheral BR, Fairman KA. The Use of Claims Databases for Outcomes Research: Rationale, Challenges, and Strategies. Clinical Therapeutics. 1997; 19(2):346-366.

Motheral BR, Fairman KA, Teitelbaum F, et al. Factors influencing utilization and costs in a pharmacy benefit program. Drug Benefit Trends. 1996;October:10-18, 34.

Fairman KA, Teitelbaum F, Motheral BR, Barrow SM, Thomas ME. Comment on Horn et al.’s “Intended and Unintended Consequences of HMO Cost-Containment Strategies.” American Journal of Managed Care 1996;2:588,591-592